je.st
news
Pharmaxis shares soar on German deal
2015-05-18 10:30:20| Biotech - Topix.net
Biotech Pharmaxis has sold an anti-inflammatory drug it was developing to Germany's Boehringer Ingelheim in a deal worth up to $750 million. The news pushed Pharmaxis shares to a two year high, gaining 8.5 cents, or 51.5 per cent, to 25 cents.
Tags: deal
german
shares
soar
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||